|
|
|
| Brand | Other Names | Presentation | Strengths | Enquire |
| Ursofalk ® | ursodeoxycholic acid | Suspension | 250 mg/5 mL x 250 mL | |
| Capsules | 250 mg x 100 |
| TGA indication | |
| URSOFALK is indicated in the treatment of chronic cholestatic liver diseases. | |
| PBS listing | |
URSOFALK capsules: Authority required (STREAMLINED).
1700 Primary biliary cirrhosis.
Note:Not for use in the treatment of sclerosing cholangitis or cholelithiasis.
URSOFALK suspension is not listed on the PBS. | |
| Information for Patients | |
| Consumer Medicine Information | |
| Information for Healthcare Professionals | |
| Product Information | |
